NCT04442893

Brief Summary

This study will explore the effect of Rumination-Focused Cognitive Behaviour Therapy on depressive symptoms in patients with schizophrenia for three months. A randomized controlled trial is conducted in a psychiatric center in northern Taiwan. All participants are randomized to two groups using blocked randomization. The experimental groups are provided with a 6- session RFCBT program for 12 weeks (60-90 mins, once every two weeks), while the control groups receive a 6- session Health Education program for 12 weeks (60-90 mins, once every two weeks). All participants who suffered from depressive symptoms at both baseline and 3-month follow-up will be evaluated using the Beck Depression Inventory(BDI-II), Chinese Response Style Questionnaire-short form revised(CRSQ-10), Internalized Stigma of Mental Illness (ISMI) Scale, and Herth Hope Index Chinese Version(HHI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 22, 2019

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 18, 2019

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

September 2, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 16, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 23, 2020

Completed
3.4 years until next milestone

Results Posted

Study results publicly available

November 9, 2023

Completed
Last Updated

November 9, 2023

Status Verified

November 1, 2023

Enrollment Period

27 days

First QC Date

September 2, 2019

Results QC Date

August 24, 2020

Last Update Submit

November 7, 2023

Conditions

Keywords

Rumination-Focused Cognitive Behaviour Therapy(RFCBT)depressive symptomSchizophrenia

Outcome Measures

Primary Outcomes (2)

  • Beck Depression Inventory (BDI-II)

    The Beck Depression Inventory-II (BDI-II) is a 21-item self-report depression screening measure. Each item is rated on a four-point Likert-type scale ranging from 0 to 3, which with possible scores ranging from 0 to 63. The BDI-II has been translated into a Chinese version. Higher total scores indicate more severe depressive symptoms, and a score of \>16 points is considered suggestive of the presence of clinically significant depressive symptom intensity. In this study, the investigators will explore the change of BDI-II score among baseline, after intervention and three-month follow-up.

    For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).

  • Chinese Response Style Questionnaire-short Form Revised (CRSQ-10)

    The Chinese Response Style Questionnaire-short form revised (CRSQ-10) is a self-report measure of rumination, comprising ten items and describing the factors of brooding and reflection. Each item is rated on a four-point Likert-type scale ranging from 1 (strongly disagree) to 4 (strongly agree), which with possible scores ranging from 10 to 40. The CRSQ-10 has been used to evaluate the intensity of ruminative responses to depressed mood. In this study, the investigators will explore the change of CRSQ-10 score among baseline, after intervention and three-month follow-up.

    For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).

Secondary Outcomes (2)

  • The Internalized Stigma of Mental Illness (ISMI) Scale

    For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).

  • Herth Hope Index Chinese Version(HHI)

    For two study groups, the measure time points are at baseline(T0), after intervention (T1) and three-month follow-up (T2).

Study Arms (2)

Experimental group

EXPERIMENTAL

The experimental group would be provided with a 6- session RFCBT program for 12 weeks (60-90 mins, once every two weeks).

Behavioral: Rumination-Focused Cognitive Behaviour Therapy

Control group

OTHER

The control group would receive a 6- session Health Education program for 12 weeks (60-90 mins, once every two weeks)

Other: Health Education programme

Interventions

Rumination-Focused Cognitive Behavioural Therapy(RFCBT) is based on a differentiation between functional and dysfunctional styles of perseverative thinking with the helpful style characterized as a concrete, process-focused and specific style of thinking and the idea that rumination is a habit maintained by negative reinforcement. In line with the theoretical assumptions, RFCBT combines strategies from behavioral activation with strategies to foster concrete, process-focused and specific thinking.

Experimental group

Health education programme would be any planned activity or set of activities aimed at increasing health literacy and developing life skills conducing to health (e.g. decision making, problem solving, critical thinking, interpersonal skills, stress management, coping with emotions).

Control group

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The participants are diagnosed with schizophrenia by Diagnostic and Statistical Manual of Mental Disorders, Five Edition (DSM-V), an age of between 20 and 65 years, hospitalization in a rehabilitation unit, and a stable condition at the time of data collection.
  • The participants are able to provide written informed consent and comprehend the instruments.
  • The participants consent to receive a 6- session RFCBT program or a 6- session Health Education program and complete a package of questionnaires.
  • The participants are satisfied the screening criteria including the Positive and Negative Syndrome Scale (PANSS) for positive syndromes \< 5, the Mini-Mental State Examination (MMSE) ≥ 24, and the Brief Symptom Rating Scale (BSRS-5) ≥ 6.

You may not qualify if:

  • The participants who have intellectual disturbances (organic mental disorders) or substance abuse issues through a chart review.
  • The participants who are not willing to sign the consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Yang-Ming University

Taipei, Taiwan

Location

MeSH Terms

Conditions

DepressionSchizophrenia

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorSchizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Results Point of Contact

Title
Chiu-Yueh Yang, Professor
Organization
National Yang Ming University

Study Officials

  • Chiu-Yueh Yang, PhD

    National Yang Ming Chiao Tung University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The data of PANSS were collected by a research assistant.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The participants were divided into experimental and control groups through block randomization
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Nursing Department

Study Record Dates

First Submitted

September 2, 2019

First Posted

June 23, 2020

Study Start

July 22, 2019

Primary Completion

August 18, 2019

Study Completion

March 16, 2020

Last Updated

November 9, 2023

Results First Posted

November 9, 2023

Record last verified: 2023-11

Locations